Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
100.79
-1.76 (-1.72%)
Dec 5, 2025, 4:00 PM EST - Market closed
Revenue Breakdown
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | 2015 - 2020 |
| Discovery & Analytical Solutions Product Revenue (Pre-Q3 2022) | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Discovery & Analytical Solutions Service Revenue (Pre-Q3 2022) | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Total Discovery & Analytical Solutions Revenue (Pre-Q3 2022) | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Total Diagnostics Revenue (Pre-Q3 2022) | 1.43B | 1.50B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | 1.39B | 1.25B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 2.81B | 2.76B |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown 2
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | 2015 - 2020 |
| Total Discovery & Analytical Solutions Revenue (Post-Q2 2022) | 1.39B | 1.25B |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Product Revenue (Pre-Q3 2022) | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Service Revenue (Pre-Q3 2022) | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Total Diagnostics Revenue (Pre-Q3 2022) | 1.43B | 1.50B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 2.81B | 2.76B |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown 3
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | 2015 - 2020 |
| Total Diagnostics Revenue (Pre-Q3 2022) | 1.43B | 1.50B |
Log In |
Log In |
Log In | Upgrade
|
| Total Product Revenue | 2.31B | 2.34B |
Log In |
Log In |
Log In | Upgrade
|
| Total Service Revenue | 503.59M | 416.82M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 2.81B | 2.76B |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown 4
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | 2015 - 2020 |
| Life Sciences Revenue (Pre-Q3 2022) | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Applied Markets Revenue (Pre-Q3 2022) | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 2.81B | 2.76B |
Log In |
Log In |
Log In | Upgrade
|
EBIT
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | 2015 - 2020 |
| Discovery & Analytical Solutions Operating Income (Pre-Q3 2022) | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | 363.64M | 346.74M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 363.64M | 346.74M |
Log In |
Log In |
Log In | Upgrade
|
EBIT 2
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | 2015 - 2020 |
| Discovery & Analytical Solutions Operating Income (Post-Q2 2022) | 453.14M | 448.02M |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics Operating Income (Pre-Q3 2022) | 351.23M | 373.19M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 363.64M | 346.74M |
Log In |
Log In |
Log In | Upgrade
|
EBIT 3
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2015 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 | 2015 - 2020 |
| Diagnostics Operating Income (Pre-Q3 2022) | 351.23M | 373.19M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 363.64M | 346.74M |
Log In |
Log In |
Log In | Upgrade
|